Company intelligence / Profile preview

CBSET

Lexington, Massachusetts, United States

Ownership: Private
Development stage: Preclinical

Overview

CBSET provides GLP-compliant, AAALAC-accredited preclinical research services supporting medical device and therapeutic development from proof-of-concept through IND-enabling studies. It has enabled over 400 MedTech and BioTech companies to advance novel technologies toward clinical trials and regulatory approval. As a service provider/CRO, it does not have its own clinical results or pipeline.

Therapeutic areas: OtherDermatologyCardiovascularNephrologyWomen's Health
Modalities: Small moleculeBiologicCell therapyDevice (Medical device)Gene therapyCombination product (drug-device)
Industry: Contract Research Organization

Partnerships

Has partnered with more than 400 MedTech/BioTech companies since founding; specific partners are confidential/not publicly listed.

Beyond the preview

Go deeper on CBSET.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CBSET.

Explore the full profile